BIRC5 and neoplasm: In a second step, the results were statistically correlated with clinicopathological parameters and post-operative patient survival data to assess the potential therapeutic and prognostic relevance of survivin in the treatment of PDAC in accordance with the “Reporting Recommendations for Tumour Marker Prognostic Studies (REMARK)” [25].